Elevation Oncology Inc
Change company Symbol lookup
Select an option...
ELEV Elevation Oncology Inc
CPSI Computer Programs and Systems Inc
TKNO Alpha Teknova Inc
BTM Bitcoin Depot Inc
RC Ready Capital Corp
NEOV NeoVolta Inc
SCHL Scholastic Corp
SIDU Sidus Space Inc
MGY Magnolia Oil & Gas Corp
CWBR CohBar Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Elevation Oncology, Inc. is an oncology company. The Company is focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. Its lead product candidate, EO-3021 (SYSA1801 or CPO102), is an antibody-drug conjugate (ADC) designed to target Claudin 18.2, a clinically validated molecular target, which can selectively deliver a cytotoxic payload directly to cancer cells expressing Claudin 18.2. Claudin 18.2 is expressed across several solid tumor types, including many gastrointestinal cancers such as gastric, gastroesophageal junction and pancreatic cancer. Claudin 18.2 is also expressed in ovarian cancer, non-small cell lung cancer (NSCLC) and other solid tumors. The Company is exploring opportunities through new or existing partnerships and business development opportunities to expand its novel oncology pipeline.

Closing Price
$0.70
Day's Change
-0.0164 (-2.29%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.72
Day's Low
0.6822
Volume
(Light)
Volume:
32,471

10-day average volume:
182,845
32,471
Historical quotes & splits
  • Prev Close
    0.7164
  • Today's Open
    0.6822
  • Day's Range
    0.6822-0.72
  • Avg Vol (10-day)
    182.8K
  • Last (time)
    3:59p ET 09/22/23
  • Last (size)
    2
  • 52-Wk Range
    0.645 - 5.89
    LowHigh
  • % Above Low

    % Above Low

    The current share price compared to the 52-week low.

    (05/26/23 - 09/15/23)
    8.53%
  • Historical Volatility

    Historical Volatility

    The volatility of a stock over a given time period. It is calculated by determining the average standard deviation from the average price of the stock over one month or 21 business days. Historical volatility can be compared with implied volatility to determine if a stock's options are over- or undervalued.

    147.1%
  • Market Cap
    29.7M
  • Shares Outstanding
    42.4M
  • EPS (TTM, GAAP)

    EPS (TTM, GAAP)

    GAAP EPS (TTM) refers to a company's earnings per share (EPS) for the trailing twelve-month (TTM) period. EPS is calculated by dividing the adjusted income available to common stockholders for the trailing twelve months by the trailing twelve-month diluted weighted average shares outstanding.

    GAAP vs. Non-GAAP Earnings

    TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.

    -3.57
  • P/E Ratio (TTM, GAAP)

    P/E Ratio (TTM, GAAP)

    GAAP P/E is a relative valuation measure used to determine if a stock is expensive in relation to its peers. It is calculated by dividing the current stock price by the sum of the Diluted Earnings Per Share from continuing operations BEFORE Extraordinary Items and Accounting Changes over the last reported 12 months.

    GAAP vs. Non-GAAP Earnings

    TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.

    --
  • Annual Dividend/Yield

    Annual Dividend/Yield

    Annual Dividend is calculated by multiplying the announced next regular dividend amount times the annual payment frequency. If no new dividend has been announced, the most recent dividend is used. If dividend payments are inconsistent, as with many ADRs, the annual dividend is calculated by totaling the regular dividends paid over the trailing 12 months. Annual Dividend/yield calculations do not guarantee or imply future payment of dividends.

    No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • Beta

    Beta

    The measure of a security's volatility in relation to the S&P 500. Beta less than 1 means the security's price or NAV has been less volatile than the market. Beta greater than 1 means the security's price or NAV has been more volatile than the market.

    --
  • % Held by Institutions

    % Held by Institutions

    Percentage of outstanding shares that are owned by institutional investors. Calculated from current quarterly filing as of today.

    79.83
  • Short Interest

    Short Interest

    The number of shares of a security that have been sold short by investors. It is typically expressed as a percentage of the total number of shares outstanding and is reported on a monthly basis.

    (% of float 08/31/23)
    3.13

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.

3rd Party Research Disclosure